The "Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions Training Course" training has been added to ResearchAndMarkets.com's offering. Every biotech product ...

It is expected that representatives for MSMEs pharma manufacturers may raise the issue of extension of Revised Schedule M ...

PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company (“PHAXIAM” or “the Company”) developing innovative ...

This June, a group of architecture students from around the world have the chance to envision a greener future for one of Houston’s most recognizable skyscrapers—the ExxonMobil Building—as part of a ...

Canadian producer Aurora Cannabis has delivered its first flower product in Germany’s growing medical marijuana market.

The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...

Kolkata: The West Bengal health dept asked a saline manufacturing unit, which is a major supplier to govt hospitals, to stop manufacturing the product.

It has been classified as a Class II recall by the FDA, which is a situation in which use of, or exposure to, a violative ...

Bioxyne lifts revenue 77% QoQ; Radiopharm listed on the Nasdaq in the December quarter; Tryptomine hits key milestones; Quarterly season is nearing its end, triggering a rush from ...

As part of its enforcement activities, the Food and Drug Administration (FDA) sends warning letters to entities under its jurisdiction. Some letters are ...

Addressing Critical U.S. Vulnerabilities in Vaccine Supply and National Preparedness ATLANTA, GA - January 29, 2025 ...